AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05531331 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: At home education via video conferencing
Description: Educational booklets are given according to the type of stoma. The individual with the stoma was told that the researcher was always reachable by phone and could communicate if he had any problems. The individuals with stoma in the experimental group received the training of the company representative that sells stoma materials, which is routinely given in the hospital. After discharge, training was given by the researcher via video conference in a total of four interviews. The first interview was done on the 5th day after discharge, the second on the 10th day, the third on the 15th day, and the fourth on the 2nd month. A post-test was conducted at the end of the 4th training interview, which was administered via video conferencing.
Study NCT06198647 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tui-na massage
Description: Using Tui-na massage for the back muscles
Study NCT06198647 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: positional release technique
Description: using positional release manual technique to relax the back muscles
Study NCT04892589 — intervention group
Intervention type: OTHER
Intervention: Proprioceptive thumb exercises.
Description: Exercises for recognition of thumb position and thumb force sense.
Study NCT06473714 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: Transcranial direct current stimulation of the dorsolateral prefrontal cortex will be made at 1,5mA
Study NCT06473714 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM
Description: Transcranial direct current stimulation of the dorsolateral prefrontal cortex will not be made. The electrodes are placed on the skull and a slight but non-continuous intensity is applied.
Study NCT06377319 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac Output Response to Stress (CORS) test
Description: Cardiac Output Response to Stress (CORS) is a novel, non-invasive, easy-to-use test developed by the Newcastle and Coventry Universities. CORS test measures heart function (cardiac output) at rest and in response to short step-exercise using validated electrical signal processing bioreactance technology, similar to an ECG.
Study NCT00000884 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
Description: Dosage will vary based on route of administration
Study NCT00000884 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ALVAC-HIV MN120TMG (vCP205)
Description: Dosage will vary based on route of administration
Study NCT00000884 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ALVAC-RG Rabies Glycoprotein (vCP65)
Description: Dosage will vary based on route of administration
Study NCT05996120 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hypothermic Cardiopulmonary Bypass
Description: Mild hypothermia (between 32 - 35 °C) during cardiopulmonary bypass
Study NCT05996120 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Normothermic Cardiopulmonary Bypass
Description: Normothermia (active maintenance of temperature between 36.5 °C to 37.5°C; no active cooling below 36.5 °C) during cardiopulmonary bypass
Study NCT06312059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Advance Infant Formula Powder
Description: Sole source infant nutrition for the control arm.
Study NCT06450158 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot (Amadeo)-assisted Training
Description: Amadeo® is an FDA Class I Exempt hand/finger robot that has the capacity to precisely measure hand/finger functions.~To use Amadeo, a participant will be seated in a chair. The height of the robot arm support will be adjusted to achieve a comfortable position for the participant. One of the participant's arms will be will be placed on the robot arm support. Magnetic finger tips will then be attached to fingers and thumb. After this, fingers and thumb will be connected to the robot finger sliders. To use Amadeo, the movement range and maximal force of each finger will be configured according to the finger's capability. The following four types of function assessments will be performed with Amadeo: Force, range of motion, tone, and spasticity. Each session will last approximately one hour.
Study NCT06201663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romiplostim
Description: Weekly subcutaneous injections
Study NCT06180746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Knowledge mobilization to facilitate the structuring of health mediation
Description: The ECEMSo intervention involves knowledge mobilization to facilitate the structuring of health mediation throughout French territory, and the development of a co-designed effective action plan to facilitate cancer screening uptake by people living in informal housing.~The action plan will, consider territorial specificities at the regional level. The ECEMSo project team will organize a seminar and three workshops. The aim of the seminar and workshops is to mobilize knowledge to facilitate i) the structuring of health mediation in the regions, and ii) the development of an action plan with health mediators and other stakeholders to foster organized cancer screenings uptake by underserved people. This action plan must match with the needs of people living in informal housing, and must be coordinated, suitable and feasible to implement, in terms of knowledge about people living in informal housing specificities and specific local collaborations
Study NCT05328674 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic reconstruction of cartilage defects in the knee joint with the use of autogenous cartilage transplant with PRP GF (platelet plasma with growth factor)
Description: Arthroscopic reconstruction of cartilage defects in the knee joint using an autogenous PRP GF cartilage transplant.
Study NCT05328674 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic reconstruction of the cartilage defects of the knee joint using the microfracture method
Description: Arthroscopic reconstruction of the cartilage defects of the knee joint using the microfracture method.
Study NCT06112548 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: primary unilateral TKA
Description: Primary unilateral total knee arthroplasty with cruciate scarifying cemented DePuy Synthes PFC Sigma prosthesis.
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacain
Description: low body weight (0.50%, 20cc) intraoperative periarticular injection
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ketorolac
Description: 1ml of 30mg/ml ketorolac intraoperative periarticular injection
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epinephrine
Description: 0.5ml Adrenaline 1mg/ml intraoperative periarticular injection
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: IV Paracetamol \[Ofirmev\] introduced every 6 hours after surgery
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketorolac
Description: IV Ketorolac {Toradol} introduced every 12 hours after surgery.
Study NCT06112548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: IV Tramadol \[Ultram\] introduced when needed after surgery
Study NCT04864418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AST-021p
Description: 3 priming immunization (2weeks x3) in 4 cohort groups (1.2mg, 2.4mg, 3.6mg and 4.8mg AST-021p) if possible, 3 boosting immunization (4weeks x 3) in cohort groups after priming immunization
Study NCT05351021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: cidophage 850 gm twice daily
Study NCT05351021 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo twice daily for treatment period
Study NCT06312059 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kendamil Cow milk test product
Description: Sole source infant nutrition for the cow milk test arm.
Study NCT06312059 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kendamil goat milk test product
Description: Sole source infant nutrition for the goat milk test arm.
Study NCT06168344 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-Based Education Program
Description: This study was assessed the impact of a web-based education program provided to mothers of infants with congenital heart diseases on their quality of life and self-efficacy levels
Study NCT04849273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPX-0131
Description: Oral TPX-0131 tablets
Study NCT05888454 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrative Group Program
Description: The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.
Study NCT05888454 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment for T2DM
Description: Conventional medical treatment for T2DM
Study NCT05888454 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment for T2DM
Description: Conventional medical treatment for T2DM
Study NCT04906239 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae Plane Block
Description: A high-frequency ultrasound linear probe, covered with a sterile sheath, will be placed approximately 2 cm to the right or left of the T 4-5 spinous process. After showing the T 4-5 transverse process and the erector spinae muscle on top of it, a 22-gauge, 80 mm insulated quincke type needle will be inserted into the skin at an angle of approximately 30 degrees from cranial to caudal, using the in-plane technique. When the transverse process is touched, the needle will be pulled out and after a negative aspiration test with 0.5 mL of normal saline and after the demonstration of a hypo-echogenic image and hydro dissection, a local anesthetic solution will be applied to the fascia beneath the erector spinae muscle. A 20 mL dose of 0.25% bupivacaine, which has been shown to spread both above and below the T 4-5 level, will be injected.
Study NCT05059639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almond
Description: Consume 2 ounces of almond daily for 8 weeks
Study NCT05059639 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pretzel
Description: Consume comparative amount of pretzel daily for 8 weeks
Study NCT06681844 — intervention group
Intervention type: OTHER
Intervention: Tooth Shape assessed using an intraoral scanner one after avulsion
Description: * Tooth Shape assessed using an intraoral scanner one after avulsion and stored as StereoLithography (STL) file~* Age, gender, reason of avulsion, type of tooth taken from the database and stored in a google sheet
Study NCT06680713 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Progressive exercise testing on a cyclo ergometer
Study NCT04791488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Description: Hyperbaric oxygen therapy protocol
Study NCT04791488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diving simulation
Description: Hyperbaric chamber diving simulation protocol
Study NCT06472271 — intervention group
Intervention type: DRUG
Intervention: Polymyxin e
Description: Increased starting colistin dose
Study NCT06467851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suanzaoren Decoction and Huanglian Wenda Decoction
Description: Twice daily. Chinese herbal medicine includes: 25 grams of Suanzaoren, 10 grams of chuanxiong, 30 grams of fushen, 10 grams of Polygala tenuifolia, 10 grams of Pinellia ternata, 12 grams of tangerine peel, 15 grams of Zhuru, 30 grams of forged keel, 30 grams of forged oyster,10 grams of aurantii fructus, 6 grams of coptis chinensis, 30 grams of Albizzia bark.Add or subtract Chinese herbal medicine according to the different clinical manifestations of each patient.
Study NCT05231044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KX01 ointment 1%
Description: The experimental drug, KX01 Ointment 1% is used in participants with Clinically typical AK on the face or scalp.
Study NCT05231044 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vehicle Ointment is used in participants with Clinically typical AK on the face or scalp.
Study NCT05693116 — intervention group
Intervention type: PROCEDURE
Intervention: Rhinectomy
Description: Surgery will be performed according to extension of the tumour, i.e. local resection limited to the vestibule, partial rhinectomy, total rhinectomy, extended total rhinectomy
Study NCT06539247 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Motor Relearning Program with Electrical Muscle Stimulation (MRA + EMS)
Description: This arm received a 30-minute motor relearning program focused on improving foot drop and gait patterns and Electrical Muscle Stimulation (EMS) for Targeted Activation (10 minutes) with 40 mA (default) adaptive, considering both intensity and duration for safe foot lift during walking.
Study NCT06539247 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation Technique with Electrical Muscle Stimulation (PNF + EMS)
Description: This arm received a 30-minute intervention combining Proprioceptive Neuromuscular Facilitation (PNF) techniques and EMS. The program consisted of:~PNF Techniques for Neuromuscular Facilitation (20 minutes) and Electrical Muscle Stimulation (EMS) for Muscle Response Enhancement (10 minutes): Similar to Arm 1, EMS applied to the affected ankle dorsiflexors for 10 minutes with the same parameters.
Study NCT06131554 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection
Study NCT06131554 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 2 of MCV4
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection
Study NCT06131554 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 3 of MCV4
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection
Study NCT06131554 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Description: 1 dose of Menactra (0.5ml) on Day 0, Intramuscular injection
Study NCT05333315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP1
Description: IP1: 2 softchews 3 times a day before meals with 1-2 glasses of water for eight weeks.~OTHER: Placebo
Study NCT05333315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP2
Description: IP2: One bag per day mixed in 200 mL of cold water or tea and consumed immediately, on an empty stomach, half an hour before breakfast for eight weeks.~OTHER: Placebo
Study NCT06468137 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Swedish I-ACE
Description: Rehabilitative programme with focus on communication strategies and problem solving for people with hearing loss.
Study NCT06038097 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Pallidotomy
Description: Radiofrequency bilateral simultaneous pallidotomy
Study NCT06468137 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Clinical visit
Description: Visit in the clinic with focus on audiologic rehabilitation.
Study NCT06468137 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No follow-up
Description: Participants choosing no follow-up.
Study NCT05021848 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: partnered multicomponent exercises program
Description: aerobic,strength, flexibility and balance exercises and game
Study NCT05333315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP3
Description: IP3: One bag per day in the morning, dissolved in a glass of warm water and three capsules per day with a glass of water or tea (one capsule at breakfast, one at lunch and one at dinner) for eight weeks.~OTHER:Placebo
Study NCT05333315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP4
Description: IP4: Twice a day 20 mL half an hour before breakfast and half an hour before dinner for eight weeks.~OTHER:Placebo
Study NCT05333315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP5
Description: IP5: Formula 1: One capsule per day at breakfast with a glass of water for eight weeks and Formula 2: Two capsules a day at breakfast and at dinner with a glass of water for eight weeks.~OTHER:Placebo
Study NCT05367635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB315 for injection
Description: SKB315 for injection is an Antibody Drug Conjugates (ADC) drug targeting Claudin18.2. The strength of SKB315 is 200 mg/vial.
Study NCT05427162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prostacyclin Receptor Agonist
Description: Prostacyclin receptor agonist will be administered.
Study NCT06076954 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoolMinds
Description: CoolMinds consists of 11 adolescent sessions and 9 parent sessions to be completed simultaneously during a 14-week treatment period. The main components comprise psychoeducation, cognitive restructuring, exposure therapy, and relapse prevention. The parent program also comprises information on how to handle school absenteeism for parents and teachers or pedagogues. The intervention is mainly transdiagnostic within the anxiety disorders but also includes diagnosis specific modules and content allowing for more personalized treatment. The treatment is delivered via a telephone app but can also be accessed via computer.
Study NCT05626816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Genital Nerve Stimulation
Description: Electrical stimulation applied to the genital nerve with surface electrodes using an off the shelf TENS unit (Ultima Plus). First, an amplitude threshold for the pudendo-anal reflex responses will be determined. Then, sham (1-2 Hz) and effective stimulation (20 Hz) will be briefly applied to record responses. Then, stimulation will be applied in random presentation order to record any changes in anorectal manometry outcomes due to both sham and effective stimulation.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Clinical exam
Description: Examination by physician determines the presence of pelvic reflexes (pudendo-anal and bulbocavernosus) which are essential for GNS to have an effect.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Collection of SCI common data elements
Description: Data regarding participant demographics, history of injury, and medical history will be collected.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Bowel function survey completion
Description: Two surveys will be conducted to assess the bowel function of the participant. The International SCI Bowel Function Basic Data Set (ISCI BF BDS v2.1) and the SCI Qulaity of Life Bowel Management Difficulties (SCI-QoL BMD) survey scales collect data on overall bowel function and how any difficulties impact the participants quality of life.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: International Standard for Neurological Classification of SCI (ISNCSCI)
Description: The physician will conduct the ISNCSCI to determine the level and severity of injury to the spinal cord. This is done by determining the ability to detect light touch and pinprick stimulation. Outcomes will be a Spinal Injury Association Impairment Scale (AIS) grade of A-D.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Response to genital nerve stimulation (GNS)
Description: GNS will be applied to determine if there is a response in the participant. If the participant has no response to the stimulation they will be excluded from the second visit as it is dependent on the ability to respond to GNS.
Study NCT05626816 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Anorectal Manometry testing (ARM)
Description: The participant will be instrumented for ARM testing. This requires a special balloon catheter to be inserted into the anus and secured, surface electrode pads being applied to the anal sphincter, and electrode pads being applied to the genital nerve stimulation sites.~Once instrumented, the participant will be tested with the London Classification procedure. This procedure asks the participant to perform several actions (squeeze to withhold a bowel movement, push to have a bowel movement, and cough) as well as inflating the balloon on the catheter to determine reflex thresholds (RAIR, retroanal inhibitory reflex which relaxes the anal sphincter in response to rectal distension) and sensory thresholds (first senstation,
Study NCT05928793 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness practices
Description: Mindfulness, according to Kabat-Zinn, is to pay attention to the present moment in a purposeful way, without judgment. Being conscious involves both attention and awareness. Conscious awareness is an observer in the background of the state of consciousness, constantly observing the inner and outer environment. It is to direct our awareness and attention to our experiences in the present moment in an accepting way with our whole body and thoughts.
Study NCT05390931 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 6-session motivational interviews
Description: A total of 6 motivational interviews will be held once a month. Motivational interviews will be conducted individually.